Changes in sST2 and NT-proBNP levels predict early cardiac arrhythmia in breast cancer patients treated with anthracycline-containing chemotherapies
Early changes in sST2 and NT-proBNP levels offer additive information for early arrhythmia prediction in breast cancer patients who receive anthracycline-containing chemotherapy.
Authors
- Ying Tong (ORCID: https://orcid.org/0000-0003-2356-8398)
- Lin Guo (ORCID: https://orcid.org/0000-0002-8254-7530)
- Cuncun Chen (ORCID: https://orcid.org/0000-0001-9473-7289)
- Zhiyun Gong (ORCID: https://orcid.org/0000-0002-2071-3150)
- Tianqing Yan (ORCID: https://orcid.org/0000-0003-3410-0395)
- Suhong Xie (ORCID: https://orcid.org/0000-0003-1044-9373)
- Heng Zhang (ORCID: https://orcid.org/0000-0002-9396-7055)
- Yanchun Wang
- Minglei Jiang
- Xiaolu Ma (ORCID: https://orcid.org/0000-0002-2610-7450)
- Hui Zheng (ORCID: https://orcid.org/0000-0003-0472-528X)
- Yanan Tian (ORCID: https://orcid.org/0000-0002-9946-2998)
- Renquan Lu
Institutions
- Fudan University Shanghai Cancer Center (CN)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2024-12-12
- DOI
- https://doi.org/10.3389/fcvm.2024.1477679
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Science and Technology Commission of Shanghai Municipality